Insider Buy/Sell Details for the Healthcare Sector — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1606)
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,225
Price
$464.06
Total Value
$568.47K
Shares Held After
3,977
% of Holdings
23.5%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,322
Price
$463.26
Total Value
$612.43K
Shares Held After
5,202
% of Holdings
20.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
271
Price
$461.12
Total Value
$124.96K
Shares Held After
6,524
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
268
Price
$459.86
Total Value
$123.24K
Shares Held After
6,795
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
377
Price
$458.74
Total Value
$172.94K
Shares Held After
7,063
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
372
Price
$457.92
Total Value
$170.35K
Shares Held After
7,440
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
63
Price
$456.87
Total Value
$28.78K
Shares Held After
7,812
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
26
Price
$470.75
Total Value
$12.24K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
156
Price
$470.37
Total Value
$73.38K
Shares Held After
26
% of Holdings
85.7%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
837
Price
$469.18
Total Value
$392.70K
Shares Held After
182
% of Holdings
82.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
2,922
Price
$468.12
Total Value
$1.37M
Shares Held After
1,019
% of Holdings
74.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
596
Price
$467.09
Total Value
$278.39K
Shares Held After
3,941
% of Holdings
13.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,055
Price
$466.06
Total Value
$491.70K
Shares Held After
4,537
% of Holdings
18.9%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,794
Price
$465.11
Total Value
$834.41K
Shares Held After
5,592
% of Holdings
24.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
2,274
Price
$464.06
Total Value
$1.06M
Shares Held After
7,386
% of Holdings
23.5%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
2,456
Price
$463.26
Total Value
$1.14M
Shares Held After
9,660
% of Holdings
20.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
503
Price
$461.12
Total Value
$231.94K
Shares Held After
12,116
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
498
Price
$459.87
Total Value
$229.01K
Shares Held After
12,619
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
700
Price
$458.74
Total Value
$321.12K
Shares Held After
13,117
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
692
Price
$457.92
Total Value
$316.88K
Shares Held After
13,817
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
116
Price
$456.87
Total Value
$53.00K
Shares Held After
14,509
% of Holdings
0.8%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
3,750
Price
$39.35
Total Value
$147.56K
Shares Held After
36,010
% of Holdings
9.4%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
65,832
Price
$39.35
Total Value
$2.59M
Shares Held After
394,996
% of Holdings
14.3%
Pliant Therapeutics, Inc. (PLRX)
Cummings Keith Lamont — Chief Financial Officer
Shares
24,002
Price
$1.28
Total Value
$30.72K
Shares Held After
297,214
% of Holdings
7.5%
Pliant Therapeutics, Inc. (PLRX)
Cheung Lily — Chief Human Resource Officer
Shares
7,534
Price
$1.28
Total Value
$9.64K
Shares Held After
44,847
% of Holdings
14.4%
Pliant Therapeutics, Inc. (PLRX)
Coulie Bernard — Director
Shares
89,375
Price
$1.28
Total Value
$114.40K
Shares Held After
505,601
% of Holdings
15.0%
Pliant Therapeutics, Inc. (PLRX)
Kuo Minnie — Chief Operating Officer
Shares
6,917
Price
$1.28
Total Value
$8.85K
Shares Held After
37,806
% of Holdings
15.5%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
71,932
Price
$234.74
Total Value
$16.89M
Shares Held After
217,354
% of Holdings
24.9%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
23,948
Price
$234.74
Total Value
$5.62M
Shares Held After
99,776
% of Holdings
19.4%
Owlet, Inc. (OWLT)
Crawford Amanda — Chief Financial Officer
Shares
183
Price
$13.33
Total Value
$2.44K
Shares Held After
150,325
% of Holdings
0.1%
Owlet, Inc. (OWLT)
Harris Jonathan — President and CEO
Shares
2,311
Price
$13.33
Total Value
$30.81K
Shares Held After
264,396
% of Holdings
0.9%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
2,981
Price
$234.74
Total Value
$699.76K
Shares Held After
267,050
% of Holdings
1.1%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
19,234
Price
$234.74
Total Value
$4.51M
Shares Held After
226,615
% of Holdings
7.8%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
23,205
Price
$234.74
Total Value
$5.45M
Shares Held After
144,992
% of Holdings
13.8%
Natera, Inc. (NTRA)
Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Shares
17,806
Price
$234.74
Total Value
$4.18M
Shares Held After
177,591
% of Holdings
9.1%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$4.47
Total Value
$178.80K
Shares Held After
913,839
% of Holdings
4.2%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
3,867
Price
$35.67
Total Value
$137.94K
Shares Held After
21,354
% of Holdings
15.3%
AMICUS THERAPEUTICS, INC. (FOLD)
Campbell Bradley L — Director
Shares
75,000
Price
$14.31
Total Value
$1.07M
Shares Held After
1,021,180
% of Holdings
6.8%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
5,083
Price
$26.11
Total Value
$132.74K
Shares Held After
25,812
% of Holdings
16.5%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
5,833
Price
$26.12
Total Value
$152.33K
Shares Held After
562,080
% of Holdings
1.0%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
8,567
Price
$52.10
Total Value
$446.34K
Shares Held After
194,201
% of Holdings
4.2%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
21,433
Price
$51.61
Total Value
$1.11M
Shares Held After
202,768
% of Holdings
9.6%
Enliven Therapeutics, Inc. (ELVN)
Lyssikatos Joseph P — CHIEF SCIENTIFIC OFFICER
Shares
14,509
Price
$26.90
Total Value
$390.28K
Shares Held After
745,188
% of Holdings
1.9%
Enliven Therapeutics, Inc. (ELVN)
Lyssikatos Joseph P — CHIEF SCIENTIFIC OFFICER
Shares
5,491
Price
$26.37
Total Value
$144.81K
Shares Held After
759,697
% of Holdings
0.7%
Enliven Therapeutics, Inc. (ELVN)
Heyman Richard A. — Director
Shares
718
Price
$26.96
Total Value
$19.35K
Shares Held After
23,877
% of Holdings
2.9%
Enliven Therapeutics, Inc. (ELVN)
Heyman Richard A. — Director
Shares
512
Price
$26.46
Total Value
$13.55K
Shares Held After
24,595
% of Holdings
2.0%
NewAmsterdam Pharma Co N.V. (NAMS)
Somaiya Mayur Ian — Chief Financial Officer
Shares
19,604
Price
$32.38
Total Value
$634.78K
Shares Held After
58,382
% of Holdings
25.1%
NewAmsterdam Pharma Co N.V. (NAMS)
Somaiya Mayur Ian — Chief Financial Officer
Shares
39,712
Price
$31.78
Total Value
$1.26M
Shares Held After
77,986
% of Holdings
33.7%
NewAmsterdam Pharma Co N.V. (NAMS)
Somaiya Mayur Ian — Chief Financial Officer
Shares
900
Price
$30.64
Total Value
$27.58K
Shares Held After
117,698
% of Holdings
0.8%
ENSIGN GROUP, INC (ENSG)
Agwunobi John O — Director
Shares
246
Price
$179.82
Total Value
$44.24K
Shares Held After
9,233
% of Holdings
2.6%
Showing 351–400 of 1606 transactions (page 8 of 33)